Literature DB >> 26912383

Long-term results of combined ESWL and ERCP treatment of chronic calcific pancreatitis.

Taija Korpela1, Marianne Udd1, Andrea Tenca2, Outi Lindström1, Jorma Halttunen1, Sanna Myrskysalo3, Arto Mikkola3, Leena Kylänpää1.   

Abstract

OBJECTIVE: Extracorporeal shock wave lithotripsy (ESWL) combined with endotherapy (ET) is the standard treatment for pancreatic duct stones (PDS) in chronic pancreatitis (CP). Our aim was to report the short- and long-term results of ESWL and ET.
MATERIAL AND METHODS: Consecutively treated 83 patients with symptomatic PDS using ESWL and ET. Success was defined (i) technically: PDS fragmentation and clearance obtained and (ii) clinically: improvement/resolution of pain. To get information on quality of life, we conducted a phone survey whereby we contacted 64 (89%) patients. The long-term results are presented in those patients with ≥2 years follow-up.
RESULTS: Treated PDS with median size of 10 (5-25) mm were located in the head, body, or the tail of the pancreas in 78, 4, and 1 patients, respectively. The primary results were that technical success was achieved in 69 patients (83%) and clinical success in 66 patients (80%). Fourteen patients had technical failure, but eight of them became free of pain. Thus, clinical success can be considered to have been achieved in 74 of 83 patients (89%). In patients with persistent pseudocyst (PC) at the time of ESWL (n = 19), the PC disappeared in a year in 14 patients (74%). The long-term results were obtained from 61 (73%) ESWL- and ET-treated patients. The median follow-up for them was 53 months (range: 24-124) and 57 patients (93%) became pain-free or had less pain.
CONCLUSIONS: For patients with CP and PDS ESWL combined with ET is an effective and safe treatment giving favorable long-term results.

Entities:  

Keywords:  Endotherapy; lithotripsy; pancreatic calculi; pancreatic duct stones; shockwave

Mesh:

Year:  2016        PMID: 26912383     DOI: 10.3109/00365521.2016.1150502

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

Review 1.  A Network Meta-analysis of Surgery for Chronic Pancreatitis: Impact on Pain and Quality of Life.

Authors:  Chathura B B Ratnayake; Sivesh K Kamarajah; Benjamin P T Loveday; Manu Nayar; Kofi Oppong; Steve White; Jeremy J French; John A Windsor; Sanjay Pandanaboyana
Journal:  J Gastrointest Surg       Date:  2020-07-23       Impact factor: 3.452

2.  Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Authors:  Müjde Soytürk; Göksel Bengi; Dilek Oğuz; İsmail Hakkı Kalkan; Mehmet Yalnız; Mustafa Tahtacı; Kadir Demir; Elmas Kasap; Nevin Oruç; Nalan Gülşen Ünal; Orhan Sezgin; Osman Özdoğan; Engin Altıntaş; Serkan Yaraş; Erkan Parlak; Aydın Şeref Köksal; Murat Saruç; Hakan Ünal; Belkıs Ünsal; Süleyman Günay; Deniz Duman; Alper Yurçi; Sabite Kacar; Levent Filik
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.555

3.  Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial.

Authors:  Yang-Yang Qian; Hui Chen; Xin-Ying Tang; Xi Jiang; Wei Qian; Wen-Bin Zou; Lei Xin; Bo Li; Yan-Fen Qi; Liang-Hao Hu; Duo-Wu Zou; Zhen-Dong Jin; Dong Wang; Yi-Qi Du; Luo-Wei Wang; Feng Liu; Zhao-Shen Li; Zhuan Liao
Journal:  Trials       Date:  2017-11-02       Impact factor: 2.279

4.  Process improvement for a complex dual medical procedure.

Authors:  Wade Anthony Weigel; Michael Gluck; Andrew S Ross; Otto S Lin; Barbara L Williams; Craig C Blackmore
Journal:  BMJ Open Qual       Date:  2018-08-21

5.  Frey's procedure for chronic pancreatitis: a 10-year single-center experience in Korea.

Authors:  Hyung Sun Kim; Joo Hyung Lee; Joon Seong Park; Dong Sup Yoon
Journal:  Ann Surg Treat Res       Date:  2019-12-02       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.